Is there a role for bowel rest in nutrition management of Crohn's disease?

Wiese DM, Rivera R, Seidner DL
Nutr Clin Pract. 2008 23 (3): 309-17

PMID: 18595864 · DOI:10.1177/0884533608318674

In 1988, Greenberg and colleagues published a large randomized controlled trial to address whether bowel rest could lead to improved disease activity in patients with active Crohn's disease. The results of this study provide substantial evidence that bowel rest is not necessary to achieve remission in patients with active Crohn's disease receiving nutrition support. Before this study, great controversy existed about the use of nutrition support and bowel rest in the treatment of active Crohn's disease because of a limited number of conflicting studies providing evidence for and against its application. The results of the publication by Greenberg et al are fundamental because they helped to settle this important argument. Furthermore, this pivotal paper changed the clinical guidelines for the use of nutrition support in the management of active Crohn's disease. Since the publication of this pivotal article, many developments in the field of nutrition and in the treatment of Crohn's disease have helped validate and further its results. Subsequent studies and debate center on the use of enteral nutrition as primary treatment in patients with active Crohn's disease. Data regarding the efficacy, composition, and overall role of adult enteral nutrition in the management of Crohn's disease are presented. This article revisits the Greenberg paper and discusses some of these innovations in nutrition.

MeSH Terms (6)

Crohn Disease Enteral Nutrition Food, Formulated Humans Randomized Controlled Trials as Topic Remission Induction

Connections (1)

This publication is referenced by other Labnodes entities: